Latest Close
$1.06
News
FBLG
FibroBiologics, Inc. News
This news view pulls recent coverage and headlines tied to FBLG.
1y Change
-$10.42 (-90.77%)
Market Cap
$7,057,684.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
FibroBiologics Granted U.S. Patent Covering the Use of Fibroblasts to Enhance Survival and Function of Transplanted Insulin-Producing Islets
PR Newswire • Aug 11, 2026
Read articleFibroBiologics Granted European Patent Covering Gene Therapy for the Regeneration of Cartilage
PR Newswire • Aug 5, 2026
Read articleFibroBiologics Reports Second Quarter 2026 Financial Results; Progresses Clinical Trial Evaluating Lead Wound Care Candidate
PR Newswire • Jul 31, 2026
Read articleFibroBiologics Appoints Kathleen "Kate" Rubins, Ph.D. to Board of Directors
PR Newswire • Jul 9, 2026
Read articleFibroBiologics Completes Manufacturing of Third Batch of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
PR Newswire • Jul 7, 2026
Read articleFibroBiologics to Participate in Fireside Chat at H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
PR Newswire • Jun 30, 2026
Read article